Mayne Pharma International Pty Ltd. v. Lupin Limited et al
| Mayne Pharma International Pty Ltd. |
| Lupin Atlantis Holdings SA, Lupin Inc., Lupin Limited and Lupin Pharmaceuticals, Inc. |
| 1:2017cv01637 |
| November 13, 2017 |
| US District Court for the District of Delaware |
| Wilmington Office |
| XX Outside US |
| Mitchell S Goldberg |
| Patent |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 22, 2018. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 19
ORDER granting #18 MOTION for Pro Hac Vice Appearance of Attorney Michael K. Nutter. Signed by Judge Mitchell S. Goldberg on 1/22/2018. (nmfn)
|
| Filing 18 MOTION for Pro Hac Vice Appearance of Attorney Michael K. Nutter - filed by Lupin Atlantis Holdings SA, Lupin Pharmaceuticals, Inc.. (Attachments: #1 Certification of Michael K. Nutter)(Bilson, David) |
|
Filing 17
ORDER granting #16 MOTION for Pro Hac Vice Appearance of Attorney George F. Pappas, Michael N. Kennedy, Chanson Chang, Hwa Young Jin and Yiye Fu of COVINGTON & BURLING LLP. Signed by Judge Mitchell S. Goldberg on 1/11/2018. (nmfn)
|
| Pro Hac Vice Attorney Claire A. Fundakowski for Lupin Atlantis Holdings SA,Lupin Inc.,Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Filing 16 MOTION for Pro Hac Vice Appearance of Attorney George F. Pappas, Michael N. Kennedy, Chanson Chang, Hwa Young Jin and Yiye Fu of COVINGTON & BURLING LLP - filed by Mayne Pharma International Pty Ltd.. (Dellinger, Megan) |
|
SO ORDERED- re #15 MOTION for Pro Hac Vice Appearance of Attorney Kurt A. Mathas and Claire A. Fundakowski. Signed by Judge Sherry R. Fallon on 1/9/2018. (lih)
|
| Pro Hac Vice Attorney Kurt A. Mathas for Lupin Atlantis Holdings SA,Lupin Inc., Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Case Reassigned to Judge Mitchell S. Goldberg of the Eastern District of Pennsylvania (in lieu of Vacant Judgeship). Please include the initials of the Judge (MSG) after the case number on all documents filed. Associated Cases: 1:17-cv-01614-MSG, 1:17-cv-01637-MSG (rjb) |
| Filing 15 MOTION for Pro Hac Vice Appearance of Attorney Kurt A. Mathas and Claire A. Fundakowski - filed by Lupin Atlantis Holdings SA, Lupin Pharmaceuticals, Inc.. (Attachments: #1 Certification of Kurt A. Mathas, #2 Certification of Claire A. Fundakowski)Motions referred to Sherry R. Fallon.(Bilson, David) |
| Filing 14 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,958,161 B2; 8,715,724 B2; . (Phillips, John) |
| Filing 13 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Limited for Lupin Atlantis Holdings SA, Lupin Pharmaceuticals, Inc. filed by Lupin Atlantis Holdings SA, Lupin Pharmaceuticals, Inc.. (Phillips, John) |
| Filing 12 ANSWER to #1 Complaint, COUNTERCLAIM against All Plaintiffs by Lupin Pharmaceuticals, Inc., Lupin Atlantis Holdings SA. (Attachments: #1 Exhibit A, #2 Exhibit B)(Phillips, John) Modified on 1/9/2018 (lih). |
|
Filing 11
STIPULATION and Order Dismissing Lupin Limited and Lupin Inc. (without prejudice) by Mayne Pharma International Pty Ltd.. (Dellinger, Megan)
|
|
SO ORDERED- re #10 STIPULATION TO EXTEND TIME. Set/Reset Answer Deadlines: Lupin Atlantis Holdings SA answer due 1/5/2018; Lupin Inc. answer due 1/5/2018; Lupin Limited answer due 1/5/2018; Lupin Pharmaceuticals, Inc. answer due 1/5/2018. Signed by Judge Sherry R. Fallon on 12/1/2017. (lih)
|
| Filing 10 STIPULATION TO EXTEND TIME Within Which Defendants Shall Answer, Move, or Otherwise Respond to Plaintiff's Complaint to January 5, 2018 - filed by Lupin Atlantis Holdings SA, Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc.. (Phillips, John) |
| Filing 9 SUMMONS Returned Executed by Mayne Pharma International Pty Ltd.. Lupin Limited served on 11/16/2017, answer due 12/7/2017. (Blumenfeld, Jack) |
| Case Assigned to Vacant Judgeship (2017). Please include initials of VAC after the case number on all documents filed. Associated Cases: 1:17-cv-01614-VAC, 1:17-cv-01637-VAC (rjb) |
| CASE REFERRED to Magistrate Judge Sherry R. Fallon. (This matter has been assigned to the Vacant Judgeship and referred to a Magistrate Judge for handling through case-dispositive motions. The Magistrate Judge has full authority permitted by law to manage this matter, including entering schedules through trial, deciding non-dispositive matters and making recommendations as to the resolution of dispositive matters. Litigants and counsel are reminded that they have the option of consenting to the Magistrate Judge to handle the case in full, including trial, or consenting to having a particular motion resolved by the Magistrate Judge.) Associated Cases: 1:17-cv-01614-VAC-SRF, 1:17-cv-01637-VAC-SRF (rjb) |
| Filing 8 SUMMONS Returned Executed by Mayne Pharma International Pty Ltd.. Lupin Atlantis Holdings SA served on 11/14/2017, answer due 12/5/2017. (Blumenfeld, Jack) |
| Filing 7 SUMMONS Returned Executed by Mayne Pharma International Pty Ltd.. Lupin Pharmaceuticals, Inc. served on 11/14/2017, answer due 12/5/2017. (Blumenfeld, Jack) |
| Filing 6 SUMMONS Returned Executed by Mayne Pharma International Pty Ltd.. Lupin Inc. served on 11/14/2017, answer due 12/5/2017. (Blumenfeld, Jack) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mayne Pharma Group Limited for Mayne Pharma International Pty Ltd. filed by Mayne Pharma International Pty Ltd.. (sar) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,295,652 B1; 9,446,057 B2; 9,511,031 B2;. (sar) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or about 10/9/2017. Date of Expiration of Patent: **See Below**.Thirty Month Stay Deadline: 4/9/2020. (sar) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Lupin Atlantis Holdings SA, Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2263384.) - filed by Mayne Pharma International Pty Ltd.. (Attachments: #1 Exhibit A-D, #2 Civil Cover Sheet)(sar) |
| Summons Issued with Magistrate Consent Notice attached as to Lupin Atlantis Holdings SA on 11/13/2017; Lupin Inc. on 11/13/2017; Lupin Limited on 11/13/2017; Lupin Pharmaceuticals, Inc. on 11/13/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sar) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
